![logo](/logos/EMD.AX.webp)
Emyria Limited
ASX:EMD.AX
0.04 (AUD) • At close September 6, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | Emyria Limited |
Symbool | EMD.AX |
Munteenheid | AUD |
Prijs | 0.044 |
Beurswaarde | 17,995,516 |
Dividendpercentage | 0% |
52-weken bereik | 0.027 - 0.087 |
Industrie | Health Information Services |
Sector | Healthcare |
CEO | Dr. Stewart James Washer B.Sc., BSc (Hons), Ph.D. |
Website | https://emyria.com |
An error occurred while fetching data.
Over Emyria Limited
Emyria Limited, a clinical-stage biotech company, engages in the development of treatments for unmet medical needs. The company develops cannabinoid-based medicines, as well as MDMA drug discovery program. Its drug development program includes EMD-RX5 for treatment of psychological distress and irritable bowel syndrome; and EMD-RX7 for multiple medical conditions. The
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (AUD)
Cijfers zijn in miljoenen (AUD)